Digital Biomarkers represent a cutting-edge frontier in healthcare and medical research, offering a revolutionary approach to monitoring and assessing health using digital technologies. These biomarkers are quantifiable, objective, and measurable indicators derived from various digital sources, such as wearable devices, mobile apps, and sensors. Unlike traditional biomarkers, digital biomarkers capture real-time, continuous data, providing a dynamic and comprehensive view of an individual's health. The utilization of digital biomarkers spans a wide range of applications, including disease monitoring, drug development, and personalized healthcare. Wearable devices, for instance, can track physiological parameters, activity levels, and sleep patterns, offering valuable insights into a person's well-being. The real-time nature of digital biomarkers enables timely intervention and personalized treatment strategies. As digital biomarkers continue to evolve, they hold the promise of transforming healthcare by providing a more holistic and proactive approach to monitoring health, facilitating preventive strategies, and improving overall patient outcomes.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada